News

Filter

Current filters:

ShireEurope

Shire awards 10,000 euros to ADHD patient groups

Shire awards 10,000 euros to ADHD patient groups

13-10-2014

Ireland-based pharma company Shire announced the winners of the 2014 Excellence in ADHD Patient Group…

Adderall XREuropeHealthcareIrelandNeurologicalPharmaceuticalShireVyvanse

arGEN-X and Shire sign long term collaboration deal worth $20 million

arGEN-X and Shire sign long term collaboration deal worth $20 million

04-06-2014

Belgium-based preclinical stage biotech firm arGEN-X has entered into a long-term strategic alliance…

arGEN-XBiotechnologyBusiness FinanceEuropeHuman antibody discovery technologiesResearchShireShire Pharmaceuticals

Latest EU cost-effectiveness data for epilepsy finds benefits for Shire’s Buccolam

25-04-2014

New European economic modeling data published recently in Health Economics Review provides evidence demonstrating…

BuccolamEuropeFinancialHealthcareNeurologicalPharmaceuticalShire

Susan Kilsby to succeed Matthew Emmens as chairman of Shire

Susan Kilsby to succeed Matthew Emmens as chairman of Shire

23-01-2014

Ireland-headquartered drugmaker Shire (LSE: SHP) has announced that Susan Kilsby will become non-executive…

BoardroomEuropePharmaceuticalShire

COMPANY SPOTLIGHT

Menarini

Back to top